Neurocrine

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. 

CEO
Kyle W. Gano
CEOKyle W. Gano
Employees
1,800
Employees1,800
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1992
Founded1992
Employees
1,800
Employees1,800

NBIX Key Statistics

Market cap
13.07B
Market cap13.07B
Price-Earnings ratio
45.47
Price-Earnings ratio45.47
Dividend yield
Dividend yield
Average volume
753.92K
Average volume753.92K
High today
$134.94
High today$134.94
Low today
$131.12
Low today$131.12
Open price
$134.94
Open price$134.94
Volume
709.59K
Volume709.59K
52 Week high
$157.98
52 Week high$157.98
52 Week low
$84.23
52 Week low$84.23

NBIX News

Simply Wall St 13h
Is Neurocrine Biosciences, Inc.'s Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Neurocrine Biosciences' (NASDAQ:NBIX) stock is up by a considerable 32% over the past three months. Given that stock prices are usually aligned with a company's...

Is Neurocrine Biosciences, Inc.'s Recent Stock Performance Influenced By Its Fundamentals In Any Way?
TipRanks 4d
Neurocrine presents one-year data from study of Crenessity

Neurocrine (NBIX) Biosciences announced the presentation of new one-year data from the CAHtalyst Adult study of Crenessity showing that patients achieved lastin...

Analyst ratings

85%

of 27 ratings
Buy
85.2%
Hold
14.8%
Sell
0%

People also own

Based on the portfolios of people who own NBIX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.